Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2819)	12/29/2010 11:06:46 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ACHN was up 7.59% earlier, but is up only 4.19% at present with volume of > 138.7Ks already above its ADV.<g> The stock continues its present UT that started on Dec9 from the $2.50 level.<g> bigcharts.marketwatch.com ACHN has several anti-infective and anti-virus drugs in its pipeline and recently has had several 'analyst' recommendations. <g> achillion.com The ACTAY is $6.25 The insiders had been buying in October and reportedly hold >70% of the stock. There is also a good institutional following. <g> ACHN has > $60M in cash and relatively small LTD, but has been burning its cash at a good clip.<g> It seems that with some good news the stock could get back to the $6 level, which would be a 50% gain from present levels.<g> bigcharts.marketwatch.com Disclosure: I am long ACHN. <g> Bernard